Synutra International is an infant formula company, which operates through three segments: Nutritional Food, which includes the sale of powdered infant and adult formula products, as well as the sale of prepared foods under the brand of Huiliduo; Nutritional Supplement, which includes the production and sale of nutritional supplements, and Other Business, which includes non-core businesses, such as ancillary sales of excess or unusable ingredients and materials to industrial customers; provision of genetic diagnostic services for new born babies, and sales of cosmetics to pregnant women.

Type
Public
HQ
Rockville, US
Founded
1998
Size (employees)
2,600 (est)
Synutra International was founded in 1998 and is headquartered in Rockville, US
Report incorrect company information

Synutra International Office Locations

Synutra International has an office in Rockville
Rockville, US (HQ)
500 2275 Research Blvd
Show all (1)
Report incorrect company information

Synutra International Financials and Metrics

Synutra International Financials

Synutra International's revenue was reported to be $365.04 m in FY, 2016 which is a 11.8% decrease from the previous period.
USD

Revenue (Q3, 2017)

109.1 m

Gross profit (Q3, 2017)

42.5 m

Gross profit margin (Q3, 2017), %

38.9%

Net income (Q3, 2017)

5.1 m

EBIT (Q3, 2017)

6.9 m

Market capitalization (15-May-2017)

343 m

Closing share price (15-May-2017)

6

Cash (31-Dec-2016)

51.4 m

EV

639.7 m
Synutra International's current market capitalization is $343 m.
Annual
USDFY, 2014FY, 2015FY, 2016

Revenue

370.5 m413.9 m365 m

Revenue growth, %

12%(12%)

Cost of goods sold

217 m224.4 m188.2 m

Gross profit

153.5 m189.6 m176.8 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

88.6 m101 m86 m102.5 m115.3 m82.3 m87.3 m109.3 m77.9 m82.7 m109.1 m

Cost of goods sold

49.7 m60.7 m47.2 m58.6 m62.6 m40.4 m46.8 m53.9 m43.9 m45.4 m66.6 m

Gross profit

38.9 m40.3 m38.8 m43.9 m52.7 m41.9 m40.6 m55.4 m34 m37.3 m42.5 m

Gross profit Margin, %

44%40%45%43%46%51%46%51%44%45%39%
Annual
USDFY, 2014FY, 2015FY, 2016

Cash

90.9 m85.2 m102.7 m

Accounts Receivable

1.8 m

Inventories

84 m87.8 m98.4 m

Current Assets

285.3 m382.9 m362 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

77.5 m61.6 m41 m47.7 m85.5 m83.6 m83.9 m65.2 m79.7 m43.6 m51.4 m

Inventories

75.3 m91.8 m77.3 m84.2 m85 m110.2 m93.5 m86.9 m108.5 m120.3 m129.4 m

Current Assets

284.2 m277.3 m270 m284.1 m335.6 m408.1 m349.7 m342.3 m337.1 m295.9 m306.3 m

PP&E

127.7 m146.2 m151.8 m161.8 m180.7 m226.2 m257.9 m275 m297.1 m312.7 m302.9 m
Annual
USDFY, 2014FY, 2015FY, 2016

Net Income

30.3 m72 m21 m

Depreciation and Amortization

15.4 m15.2 m9.5 m

Inventories

(1.2 m)(18.2 m)(24.2 m)

Accounts Payable

(8.7 m)8.5 m27.8 m
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

10.8 m20.5 m18.4 m29.9 m47.8 m8 m8.6 m20.9 m(156 k)2.6 m7.8 m

Depreciation and Amortization

7 m10.6 m4.7 m7.7 m11 m2.6 m4.9 m7.2 m2.6 m5.2 m7.8 m

Inventories

14 m(1.8 m)1.1 m(7.1 m)(9.3 m)(23.7 m)(14.2 m)(10.1 m)(14.5 m)(30.8 m)(47.2 m)

Accounts Payable

(376 k)8.2 m4.8 m(1.2 m)8.9 m(2 m)(1.6 m)23.3 m(988 k)(20.5 m)9.5 m
USDY, 2016

EV/EBIT

92.9 x

EV/CFO

-21.9 x

Financial Leverage

6.1 x
Show all financial metrics
Report incorrect company information